All items in the Healthy Skepticism Library
All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 130 of 206 pages ‹ First < 128 129 130 131 132 > Last ›
HSL888
Associated Press.
Judge Dismisses Vietnamese Suit Against Makers of Agent Orange
Associated Press 2005 Mar 10
HSL892
Associated Press.
Update 1: Film Exposes Pharmaceutical Secrets
Forbes.com 2005 Mar 10
HSL937
Rovner J.
U.S. Senator Says FDA Too Cozy With Drugmakers It Regulates
MEDSCAPE 2005 Mar 10
HSL1107
Health Advocates Urge Reform of FDA Advisory Committees: Scientists Shouldn't be Passing Judgment on their Funders' Products, Groups Say
The Center for Science in the Public Interest 2005 Mar 10
HSL850
Hirschler B.
Drug Companies Export Trials to China, New Markets
Reuters 2005 Mar 9
HSL851
Reuters .
Glaxo: Justice Dept Probes Drug Pricing
REUTERS 2005 Mar 9
HSL1103
IMS Reports 2004 Global Pharmaceutical Sales Grew 7 Percent to $550 Billion: China and Biotechnology Emerge as Key Growth Drivers
IMS 2005 Mar 9
HSL5335
Garg AX, Adhikari NK, McDonald H, Rosas-Arellano MP, Devereaux PJ, Beyene J, Sam J, Haynes RB.
Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: a systematic review.
JAMA 2005 Mar 9;293:(10):1223-38
http://jama.ama-assn.org/cgi/content/full/293/10/1223
HSL5344
Koppel R, Metlay JP, Cohen A, Abaluck B, Localio AR, Kimmel SE, Strom BL.
Role of computerized physician order entry systems in facilitating medication errors.
JAMA 2005 Mar 9;293:(10):1197-203
http://jama.ama-assn.org/cgi/content/full/293/10/1197
HSL5384
Wears RL, Berg M.
Computer technology and clinical work: still waiting for Godot.
JAMA 2005 Mar 9;293:(10):1261-3
http://jama.ama-assn.org/cgi/content/full/293/10/1261
HSL852
Pear R.
Report Says Medicaid Overpays for Drugs
THE NEW YORK TIMES 2005 Mar 8
HSL887
Dubinski K, .
Lawsuit launched over antipsychotic drug
The EdmontonSun 2005 Mar 8
HSL891
Apuzzo M.
Drugs to Quit Smoking Said Show Promise
Associated Press 2005 Mar 8
HSL847
Schaefer MUÑOZ, Whalen J.
FDA Seizes Two Glaxo Drugs On Production-Quality Concerns
THE WALL STREET JOURNAL 2005 Mar 7
HSL849
Berenson A.
Pfizer Stirs Concern With Plans to Sell Heart Drugs Only as Pair
The New York Times 2005 Mar 7
HSL885
Levin M.
Merck Misled on Vaccines, Some Say: The firm supplied shots containing a mercury compound after saying it had halted its use.
THE LOS ANGELES TIMES 2005 Mar 7
HSL848
Harris G.
F.D.A. Seizes Millions of Pills From Pharmaceutical Plants
The New York Times 2005 Mar 5
HSL4955
Rosenzweig MQ, Bender CM, Brufsky AM.
The nurse as principal investigator in a pharmaceutically sponsored drug trial: considerations and challenges.
Oncol Nurs Forum 2005 Mar 5;32:(2):293-9
HSL840
Editoral .
FDA Stops Distribution Of Two Glaxo Drugs
The WALL STREET JOURNAL 2005 Mar 4
HSL841
Alonso-zaldivar R.
Senators Consider Safety Reform at FDA
THE LOS ANGELES TIMES 2005 Mar 4
HSL842
Rosack J.
FDA Tones Down Warning on Use Of Antidepressants In Children
Psychiatric News 2005 Mar 4
HSL845
Hawaleshka D.
Diane's fear factor: A controversial drug's ad campaign fuels anger
Macleans.ca 2005 Mar 4
HSL846
Glenmullen J.
Antidepressants carry risks
LJWorld.com 2005 Mar 4
HSL3769
Harris G.
Drug makers are still giving gifts to doctors, FDA officials tell senators.
NY Times (Print) 2005 Mar 4;A15
HSL839
Woodward J.
Contraceptives, antidepressants, acne meds top campus drug plans
The Gateway 2005 Mar 3
HSL843
Willman D.
New Rules Will Cost Dissidents at NIH
The LA Times 2005 Mar 3
HSL844
Wysocki B.
Some Scientists Say New Ethics Rules May Damage NIH
THE WALL STREET JOURNAL 2005 Mar 3
HSL886
Kaufman M.
Crestor May Pose Risk of Muscle Damage: FDA Issues Warning on Use of Cholesterol Drug, Especially by Asians
The Washington Post 2005 Mar 3
HSL1560
Tansey B.
Hard sell: How Marketing Drives the Pharmaceutical Industry: What FDA approval means: Agency weighs benefits, risks before drugs get to market
San Francisco Chronicle 2005 Mar 3;
HSL1109
HRT: Major Milestones - Current Perspectives on HRT and Menopause
Pharmaceutical Business Review Online 2005 Mar 2
http://www.pharmaceutical-business-review.com/research.asp?guid=DMHC2099
HSL1112
Wolfe S.
FDA Shows Dangerous Cowardice in Crestor Announcement
Public Citizen Press Health Research Group 2005 Mar 2
HSL7836
Harris G.
F.D.A. Official Admits 'Lapses' on Vioxx
New York Times 2005 Mar 2
http://www.nytimes.com/2005/03/02/politics/02fda.html?ex=1169701200&en=ff8224a9403c55a5&ei=5070
HSL512
Monarin G-L.
Proceed with caution
Med Ad News 2005 Mar;24:(3):
http://www.pharmalive.com/magazines/medad/view.cfm?articleID=1872
HSL513
The global pharmceutical industry
College Journal (Wall St Times) 2005 Mar;
http://www.collegejournal.com/researchindustries/researchindustries/pharmaceuticals-v.html
HSL883
Boyles S, Nazario B.
Does Ritalin Increase Cancer Risk in Children?: Small Study Suggests Possible Chromosome Damage, but Some Experts Skeptical
WebMD Medical News 2005 Mar 1
HSL884
Mahoney D.
New Data Mixed on Risk, Use of SSRIs in Adults
Clinical Psychiatry News 2005 Mar 1
HSL894
Batchelor S.
Funding Woes Hit Women's Health Projects
WeNews 2005 Mar 1
HSL985
Sanson G.
The myth of osteoporosis
The Candian Women's Health Network 2005 Mar 1
HSL986
Rochon-ford A.
Same Tune, Different Lyrics: The Vioxx Story
The Canadian Women's Health Network 2005 Mar 1
HSL3592
'Black box' warning added to contraceptive injection.
FDA Consum 2005 Mar-Apr 01;39:(2):3
http://www.fda.gov/fdac/departs/2005/205_upd.html
HSL3796
Amidon GL.
Collaborative research training.
Mol Pharm 2005 Mar-Apr 01;2:(2):97
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3001&uid=15804183&db=pubmed&url=http://dx.doi.org/10.1021/mp0580807
HSL3797
Van Way CW 3rd.
The great rofecoxib feeding frenzy.
JPEN J Parenter Enteral Nutr 2005 Mar-Apr 01;29:(2):136-8
http://jpen.aspenjournals.org/cgi/content/full/29/2/136
HSL4567
Haser I, Hofmann A.
[New contract recommendations for physicians cooperating with the pharmaceutical industry? The "FS Codex" and its consequences for physicians]
Orthopade 2005 Mar;34(3):263-4, 266 2005 Mar 01;34:(3):263-4, 266
HSL4953
How does PLoS medicine manage competing interests?
PLoS Med 2005 Mar 01;2:(3):e88
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pubmed&pubmedid=15783268
HSL4954
Curtiss FR.
Evidence-based medicine: United States, the last venue for direct-to-consumer advertising, props up the erectile dysfunction market.
J Manag Care Pharm 2005 Mar 01;11:(2):176-8
HSL5339
Industry sponsored meetings and events are favored by physicians
Product Management Today 2005 Mar 1;6:
HSL6006
Menighan TE.
Systems-based approach to risk management.
J Am Pharm Assoc (Wash DC) 2005 Mar-Apr 01;45:(2):116
HSL6007
Stewart D.
Beyond the sales pitch and samples.
Minn Med 2005 Mar 01;88:(3):36-7
HSL6008
Schommer JC.
Direct-to-Consumer advertising for prescription drugs.
Minn Med 2005 Mar 01;88:(3):32-3,
HSL6246
Blalock SJ, Patel RA.
Drug therapy concerns questionnaire: initial development and refinement.
J Am Pharm Assoc (Wash DC) 2005 Mar-Apr 01;45:(2):160-9
HSL987
Raven M, Rogers W, Jureidini J.
Partnerships between academic psychiatry and the pharmaceutical industry.
Australas Psychiatry 2005 Mar;13:(1):83-4
http://www.blackwell-synergy.com/openurl?genre=article&sid=nlm:pubmed&issn=1039-8562&date=2005&volume=13&issue=1&spage=83
HSL1814
Oldani MJ.
Pharma PR or medical education?
Hastings Cent Rep 2005 Mar-Apr;35:(2):6-7
HSL1815
Rentmeester CA.
Pharma PR or medical education?
Hastings Cent Rep 2005 Mar-Apr;35:(2):6
HSL1816
Roselin JM.
Pharma PR or medical education?
Hastings Cent Rep 2005 Mar-Apr;35:(2):5-6
HSL1817
Sweeney HA.
Pharma PR or medical education?
Hastings Cent Rep 2005 Mar-Apr;35:(2):4
HSL2283
De Bruin ML, Pettersson M, Meyboom RH, Hoes AW, Leufkens HG.
Anti-HERG activity and the risk of drug-induced arrhythmias and sudden death.
Eur Heart J 2005 Mar;26:(6):590-7
http://eurheartj.oxfordjournals.org/cgi/content/full/26/6/590
HSL4599
Torg J.
Vioxx and Merck: a preventable situation?
Orthopedics 2005 Mar;28:(3):248,
HSL4600
Mather C.
The pipeline and the porcupine: alternate metaphors of the physician-industry relationship.
Soc Sci Med 2005 Mar;60:(6):1323-34
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VBF-4D5JSJJ-2&_coverDate=03%2F01%2F2005&_alid=398122182&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=5925&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=a3b4c00f922432b53675cfc8e056c2cd
HSL4892
Arellano FM.
The withdrawal of rofecoxib.
Pharmacoepidemiol Drug Saf 2005 Mar;14:(3):213-7
http://www3.interscience.wiley.com/cgi-bin/abstract/109930237/ABSTRACT?CRETRY=1&SRETRY=0
HSL4897
Shatin D, Gardner JS, Stergachis A, Blough D, Graham D.
Impact of mailed warning to prescribers on the co-prescription of tramadol and antidepressants.
Pharmacoepidemiol Drug Saf 2005 Mar;14:(3):149-54
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3058&uid=15386714&db=PubMed&url=http://dx.doi.org/10.1002/pds.961
HSL5352
Nikles CJ, Clavarino AM, Del Mar CB.
Using n-of-1 trials as a clinical tool to improve prescribing.
Br J Gen Pract 2005 Mar;55:(512):175-80
http://www.ingentaconnect.com/content/rcgp/bjgp/2005/00000055/00000512/art00004?token=005d1ffc0c8db86dc67676568293c62207d673f582f6b6d383a4b3b257b507b425f246a433b316373425cf34c897f
HSL838
Herper M.
Tysabri Is No Vioxx
Forbes.com 2005 Feb 28
HSL7813
Barrett A.
Pfizer's Funk
Business Week 2005 Feb 28
http://www.businessweek.com/magazine/content/05_09/b3922001_mz001.htm?chan=search
HSL837
Tansey B.
Hard sell: How marketing drives the pharmaceutical industry: The side effects of drug promotion: Aggressive ads for painkillers left more patients exposed to risks
The San Francisco Chronicle 2005 Feb 27
HSL833
Frith M.
Dramatic increase in overdoses linked to antidepressants
The Independent 2005 Feb 25
HSL834
Harris G, Berenson A.
10 Voters on Panel Backing Pain Pills Had Industry Ties
THE NEW YORK TIMES 2005 Feb 25
HSL836
Welsh M.
Drug reactions harm, even kill, elderly: Study
The Toronto Star 2005 Feb 25
HSL1115
New CCPA study charges Health Canada with abandoning its duty to protect Canadians' health and safety
Canadian Centre for Policy Alternatives 2005 Feb 25
HSL1608
Mansfield PR.
Beliefs and plans of GP registrars before and after a 90 minute talk about drug promotion
Unpublished 2005 Feb 25;
HSL5151
Tarzwell R.
Reader's response to the webcast video editorial entitled 'the institute for one world health--a not-for-profit pharmaceutical company'.
MedGenMed 2005 Feb 25;7:(1):34
https://profreg.medscape.com/px/getlogin.do?urlCache=aHR0cDovL3d3dy5tZWRzY2FwZS5jb20vdmlld2FydGljbGUvNDk5Mzk5
HSL832
Picard A.
Drugs aren't commodities to be hustled like cars and cookies
The Boston Globe and Mail 2005 Feb 24
HSL826
Abraham C.
Health Canada too slow to act on drug-safety plan, experts say
Boston Globe and Mail 2005 Feb 23
HSL831
Are GPs in thrall to the drug companies?
The Daily Telegraph 2005 Feb 23
HSL835
Weiss R.
NIH Clears Most Researchers In Conflict-of-Interest Probe
The Washington Post 2005 Feb 23
HSL5327
Dreyfuss BT.
Patents pending
Am Prospect. 2005 Feb 23;
http://www.prospect.org/web/page.ww?section=root&name=ViewWeb&articleId=9237
HSL820
Timmons H, Wright T.
Novartis to Buy Two Makers of Generics
2005 Feb 22
HSL821
Faunce T.
Novartis hits acquisition trail
2005 Feb 22
HSL822
Martinez B.
A Vioxx Comeback Could Tilt Balance in Merck Litigation
THE WALL STREET JOURNAL 2005 Feb 22
HSL823
Winslow R, Won TESORIERO, Wilde MATHEWS.
Where Findings On Painkillers Leave Patients: FDA Panel's Recommendations Could Revive Merck's Vioxx; Balancing the Risks With Relief
THE WALL STREET JOURNAL 2005 Feb 22
HSL824
Abraham .
Weak law blamed in Vioxx case
The Boston Globe and Mail 2005 Feb 22
HSL825
Associated Press.
Another wee problem noted with HRT
Associated Press 2005 Feb 22
HSL827
BBC News.
Rules issued on patient restraint
BBC News 2005 Feb 22
HSL5575
Herxheimer A.
Communicating with Patients about Harms and Risks
PLoS Med 2005 Feb 22;2:(2):
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0020042
HSL240
Mansfield PR, Vitry AI, Wright JM.
Withdraw all COX-2-selective drugs.
Med J Aust 2005 Feb 21;182:(4):197
http://www.mja.com.au/public/issues/182_04_210205/matters_arising_210205_fm-1.html
HSL819
Carvel J.
Lack of information worries NHS patients
The Guardian 2005 Feb 21
HSL829
Canwest NEWS.
Firm to cut off drug supply: Hospitals owe thousands for Fabry drugs
Ottawa Citizen 2005 Feb 21
HSL828
Graham J, James F.
Flaws in Drug Agency Put Consumer at Risk
The Chicago Tribune 2005 Feb 20
HSL812
U.S. committee OKs all 3 arthritis drugs
CBC News 2005 Feb 19
HSL813
Wilde MATHEWS, Hensley S.
Merck May Return Vioxx to Market Move Depends on Whether FDA Panel Decides Risks Exist in Similar Medicines
THE WALL STREET JOURNAL 2005 Feb 18
HSL815
Antidepressants increase risk of suicidal behaviour: study
CBC News 2005 Feb 18
HSL19044
Larson RJ, Woloshin S, Schwartz LM, Welch HG.
Celebrity endorsements of cancer screening.
J Natl Cancer Inst 2005 Feb 18;97:(9):693-5
http://jnci.oxfordjournals.org/content/97/9/693.long
HSL814
Davis M.
FDA Maverick Whips Merck, Pfizer
TheStreet.com 2005 Feb 17
HSL830
Heavey S, Richwine L.
FDA Scientist Questions Need for COX-2 Drugs
Reuters 2005 Feb 17
HSL810
Harris G.
Drug Industry's Longtime Critic Says 'I Told You So'
The New York Times 2005 Feb 15
HSL7412
Cooper RJ, Schriger DL.
The availability of references and the sponsorship of original research cited in pharmaceutical advertisements.
CMAJ 2005 Feb 15;172:(4):487-91
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=15710940
HSL1128
UCLA study: Nearly a third of drug ads in medical journals contain no references for medical claims
University of California - Los Angeles 2005 Feb 14
HSL1130
Truth in advertising
Canadian Medical Association Journal 2005 Feb 14
HSL818
MacPherson K, Silverman E.
Drug makers now confront unlikely foe in labs: Science discovery of medicines slows despite billions in investments
The New Jersey Star-Ledger 2005 Feb 13
HSL808
Harris G.
Drug Regulators Are Trying to Quash Study, Senator Says
The New York Times 2005 Feb 12
HSL806
Meier B, Saul S.
Marketing of Vioxx: How Merck Played Game of Catch-Up
The New York Times 2005 Feb 11
Page 130 of 206 pages ‹ First < 128 129 130 131 132 > Last ›
